Discontinued — last reported Q3 '18
Viatris Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 2.7% to $1.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $1.23B to $1.21B. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.26B | $2.24B | $2.14B | $2.10B | $2.05B | $1.91B | $1.91B | $1.88B | $1.77B | $1.76B | $1.78B | $1.23B | $1.24B | $1.24B | $1.21B |
| QoQ Change | — | -0.9% | -4.3% | -2.0% | -2.3% | -6.7% | -0.2% | -1.4% | -6.0% | -0.6% | +1.3% | -30.8% | +0.2% | +0.4% | -2.7% |
| YoY Change | — | — | — | -7.0% | -8.4% | -10.7% | -9.0% | -8.2% | -7.5% | -7.9% | -5.4% | -30.3% | -29.7% | -30.4% | -2.2% |